WINDTREE THERAPEUTICS INC /DE/ Proceeds from Sale and Maturity of Marketable Securities
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Proceeds from Sale and Maturity of Marketable Securities of $13.99 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2021-03-29
- WINDTREE THERAPEUTICS INC /DE/ proceeds from sale and maturity of marketable securities for the quarter ending 2019-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from sale and maturity of marketable securities for the quarter ending 2019-09-30 was $2.50M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from sale and maturity of marketable securities for the quarter ending 2019-06-30 was $10.99M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from sale and maturity of marketable securities for the quarter ending 2019-03-31 was $499.00K.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from sale and maturity of marketable securities for fiscal 2019 was $13.99M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $2.50M derived: sum of 2 quarters · filed 2021-03-29 | $13.49M derived: sum of 3 quarters · filed 2021-03-29 | $13.99M 10-K · filed 2021-03-29 |
| 2019-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $13.49M derived: sum of 2 quarters · filed 2020-11-16 | $13.99M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $10.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $11.49M 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $499.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |